By Kate O’Rourke
New research validates the Immunoscore as a new component of a TNM-Immune classification of colorectal cancer.
Immunoscore, an in vitro diagnostic test that predicts the risk for recurrence in patients with early-stage colon cancer by measuring the immune response at the tumor site, represents a paradigm change in understanding the evolution of tumors and predicting their aggressiveness, according to its developers. The research, conducted by a consortium of 14 centers in